| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |